Early state research on antifungal natural products

Molecules

Volumn 19, Issue 3, 2014, Pages 2925-2956

  Negri, Melyssa ^a   Salci, Tânia P ^a   Shinobu Mesquita, Cristiane S ^a   Capoci, Isis R G ^a   Svidzinski, Terezinha I E ^a   Kioshima, Erika Seki ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Antifungal; Essential oils; Extracts; Fungi; Natural products

Indexed keywords

ANTIFUNGAL AGENT; BIOLOGICAL PRODUCT;

ANIMAL; CHEMISTRY; DRUG EFFECT; FUNGUS; HISTORY; HUMAN; RESEARCH; REVIEW;

ANIMALS; ANTIFUNGAL AGENTS; BIOLOGICAL PRODUCTS; FUNGI; HISTORY, 20TH CENTURY; HUMANS; RESEARCH;

EID: 84896984439     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19032925     Document Type: Article

References (214)

1. Nucci, M.; Queiroz-Telles, F.; Alvarado-Matute, T.; Tiraboschi, I.N.; Cortes, J.; Zurita, J.; Guzman-Blanco, M.; Santolaya, M.E.; Thompson, L.; Sifuentes-Osornio, J.; et al. Epidemiology of candidemia in Latin America: A laboratory-based survey. PLoS One 2013, 8, e59373.
2. Arendrup, M.C.; Dzajic, E.; Jensen, R.H.; Johansen, H.K.; Kjældgaard, P.; Knudsen, J.D.; Kristensen, L.; Leitz, C.; Lemming, L.E.; Nielsen, L. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: Data from a nationwide fungaemia surveillance programme. Clin. Microbiol. Infect. 2013, 19, 343-353.
3. Butts, A.; Krysan, D.J. Antifungal drug discovery: Something old and something new. PLoS Pathog. 2012, 8, e1002870.
4. Shao, P.L.; Huang, L.M.; Hsueh, P.R. Recent advances and challenges in the treatment of invasive fungal infections. Int. J. Antimicrob. Agents 2007, 30, 487-495.
5. Ashcroft, D.M.; Po, A.L.W. Herbal remedies. Pharmacoeconomics 1999, 16, 321-328.
6. Kathiravan, M.K.; Salake, A.B.; Chothe, A.S.; Dudhe, P.B.; Watode, R.P.; Mukta, M.S.; Gadhwe, S. The biology and chemistry of antifungal agents: A review. Bioorg. Med. Chem. 2012, 20, 5678-5698.
7. Paiva, J.A.; Pereira, J.M. New antifungal antibiotics. Curr. Opin. Infect. Dis. 2013, 26, 168-174.
8. Iwu, M. International conference on ethnomedicine and drug discovery. J. Altern. Complem. Med. 2000, 6, 3-5.
9. Orafidiya, L.O.; Oyedele, A.O.; Shittu, A.O.; Elujoba, A.A. The formulation of an effective topical antibacterial product containing Ocimum gratissimum L. leaf essential oil. Int. J. Pharm. 2001, 224, 177-183.
10. Hernández Díaz, L.; Rodríguez Jorge, M. Actividad antimicrobiana de plantas que crecen en cuba. Rev. Cuba. Plant. Med. 2001, 6, 44-47.
11. Nakamura, C.V.; Ishida, K.; Faccin, L.C.; Cortez, D.A.C.G.; Rozental, S.; de Souza, W.; Ueda-Nakamura, T. In vitro activity of essential oil from Ocimum gratissimum L against four Candida species. Res. Microbiol. 2004, 155, 579-586.
12. Wieder, L.M. Fungistatic and fungicidal effects of two wood-preserving chemicals on human dermatophytes: Ortho (2 chlorophenyl) phenol sodium and tetrachlorphenol sodium. Arch. Derm. 1935, 31, 644-657.
13. Davies, W.H.; Sexton, W.A. Chemical constitution and fungistatic action of organic sulphur compounds. Biochem. J. 1946, 40, 331-334.
14. Hopkins, J.G.; Fisher, J.K.; Hillegas, A.B.; Ledin, R.B.; Rebell, G.C.; Camp, E. Fungistatic agents for treatment of dermatophytosis. J. Invest. Dermatol. 1946, 7, 239-253.
15. Lamb, J.H. Combined therapy in histoplasmosis and coccidioidomycosis; methyltestosterone and meth-dia-mer-sulfonamides. AMA Arch. Derm. Syphilol. 1954, 70, 695-712.
16. Oxford, A.E.; Raistrick, H.; Simonart, P. Griseofulvin, C17H1706Cl, a metabolic product of Penicillium griseo-fulvum Dierckx. Biochem. J. 1939, 33, 240-248.
17. Odds, F.C. Antifungal agents: Their diversity and increasing sophistication. Mycologist 2003, 17, 51-55.
18. Brown, Hazen, E.L.; Mason, A. Effect of fungicidin (nystatin) in mice injected with lethal mixtures of aureomycin and Candida albicans. Science 1953, 117, 609-610.
19. Brown, R.; Hazen, E.L. Production of actidione by Streptomyces noursei. Antibiot. Annu. 1955, 3, 245-248.
20. Brown, R.; Hazen, E.L. Present knowledge of nystatin, an antifungal antibiotic. Trans. N. Y. Acad. Sci. 1957, 19, 447-456.
21. Brezis, M.; Rosen, S.; Silva, P.; Spokes, K.; Epstein, F.H. Polyene toxicity in renal medulla: Injury mediated by transport activity. Science 1984, 224, 66-68.
22. Gupta, A.K.; Tomas, E. New antifungal agents. Dermatol. Clin. 2003, 21, 565-576.
23. Grunberg, E.; Berger, J.; Titsworth, E. Chemotherapeutic studies on a new antifungal agent, x-5079c, effective against systemic mycoses. Am. Rev. Respir. Dis. 1961, 84, 504-506.
24. Li, M.; Liao, Y.; Chen, M.; Pan, W.; Weng, L. Antifungal susceptibilities of Cryptococcus species complex isolates from aids and non-aids patients in southeast China. Braz. J. Infect. Dis. 2012, 16, 175-179.
25. Heeres, J.; Meerpoel, L.; Lewi, P. Conazoles. Molecules 2010, 15, 4129-4188.
26. Gleason, T.G.; May, A.K.; Caparelli, D.; Farr, B.M.; Sawyer, R.G. Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units. Arch. Surg. 1997, 132, 1197-1201.
27. Salci, T.P.; Gimenes, M.; dos Santos, C.A.; Svidzinski, T.I.E.; Caparroz-Assef, S.M. Utilization of fluconazole in an intensive care unit at a university hospital in Brazil. Int. J. Clin. Pharm. 2013, 35, 176-180.
28. Odds, F.C.; Brown, A.J.P.; Gow, N.A.R. Antifungal agents: Mechanisms of action. Trends Microbiol. 2003, 11, 272-279.
29. Barrett, D. From natural products to clinically useful antifungals. Biochim. Biophys. Acta 2002, 1587, 224-233.
30. Denning, D.W. Echinocandin antifungal drugs. Lancet 2003, 362, 1142-1151.
31. Cappelletty, D.; Eiselstein-McKitrick, K. The echinocandins. Pharmacotherapy 2007, 27, 369-388.
32. Pappas, P.G.; Kauffman, C.A.; Andes, D.; Benjamin, D.K., Jr.; Calandra, T.F.; Edwards, J.E., Jr.; Filler, S.G.; Fisher, J.F.; Kullberg, B.J.; Ostrosky-Zeichner, L. Guías de práctica clínica para el manejo de la candidiasis: Actualización del 2009, de la infectious diseases society of america. Clin. Infect. Dis. 2009, 48, 503-537.
33. Herreros, E.; Martinez, C.M.; Almela, M.J.; Marriot, M.S.; de las Heras, F.G.; Gargallo-Viola, D. Sordarins: In vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis. carinii and filamentous fungi. Antimicrob. Agents Chemother. 1998, 42, 2863-2869.
34. Clemons, K.V.; Stevens, D.A. Efficacies of sordarin derivatives gm193663, gm211676, and gm237354 in a murine model of systemic coccidioidomycosis. P6. Antimicrob. Agents Chemother. 2000, 44, 1874-1877.
35. Castro, J.; Cuevas, J.C.; Fiandor, J.M.; Fraile, M.T.; Gomez De Las Heras, F.; Ruiz, J.R. Antifungal sordarins. Part 3: Synthesis and structure-activity relationships of 2',3'-fused oxirane derivatives. Bioorg. Med. Chem. Lett. 2002, 12, 1371-1374.
36. Kamai, Y.; Kakuta, M.; Shibayama, T.; Fukuoka, T.; Kuwahara, S. Antifungal activities of r-135853, a sordarin derivative, in experimental candidiasis in mice. Antimicrob. Agents Chemother. 2005, 49, 52-56.
37. Hanadate, T.; Tomishima, M.; Shiraishi, N.; Tanabe, D.; Morikawa, H.; Barrett, D.; Matsumoto, S.; Ohtomo, K.; Maki, K. Fr290581, a novel sordarin derivative: Synthesis and antifungal activity. Bioorg. Med. Chem. Lett. 2009, 19, 1465-1468.
38. Ostrosky-Zeichner, L.; Casadevall, A.; Galgiani, J.N.; Odds, F.C.; Rex, J.H. An insight into the antifungal pipeline: Selected new molecules and beyond. Nat. Rev. Drug Discov. 2010, 9, 719-727.
39. Pfaller, M.A.; Castanheira, M.; Messer, S.A.; Moet, G.J.; Jones, R.N. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans and Aspergillus. fumigatus: Application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the Sentry Antimicrobial Surveillance Program (2009). Diagn. Microbiol. Infect. Dis. 2011, 69, 45-50.
40. Pfaller, M.A.; Duncanson, F.; Messer, S.A.; Moet, G.J.; Jones, R.N.; Castanheira, M. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods. Antimicrob. Agents Chemother. 2011, 55, 5155-5158.
41. Hata, K.; Horii, T.; Miyazaki, M.; Watanabe, N.-A.; Okubo, M.; Sonoda, J.; Nakamoto, K.; Tanaka, K.; Shirotori, S.; Mura, N.; et al. Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis. Antimicrob. Agents Chemother. 2011, 55, 4543-4551.
42. Miyazaki, M.; Horii, T.; Hata, K.; Watanabe, N.A.; Nakamoto, K.; Tanaka, K.; Shirotori, S.; Murai, N.; Inoue, S.; Matsukura, M.; et al. In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds. Antimicrob. Agents Chemother. 2011, 55, 4652-4658.
43. U.S. Food and Drug Administration. Informations for Clinical Investigators (INDs). Available online: Http://www.fda.gov/Drugs/ DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/ InvestigationalNewDrugINDApplic ation/ucm176259.htm (accessed on 16 January 2014).
44. Hope, P.R.P. Intellectual property protections are vital to continuing innovation in the biopharmaceutical industry. 2013. Available online: Http://www.phrma.org/innovation/intellectual-property (accessed on 16 January 2014). 45. Drews, J. Drug discovery: A historical perspective. Science 2000, 287, 1960-1964.
45. Takeshita, H.; Watanabe, J.; Kimura, Y.; Kawakami, K.; Takahashi, H.; Takemura, M.; Kitamura, A.; Someya, K.; Nakajima, R. Novel pyridobenzimidazole derivatives exhibiting antifungal activity by the inhibition of beta-1,6-glucan synthesis. Bioorg. Med. Chem. Lett. 2010, 20, 3893-3896.
46. Kuroyanagi, J.; Sugimoto, Y.; Fujisawa, T.; Morita, C.; Suzuki, T.; Kawakami, K.; Takemura, M. Novel antifungal agents: Triazolopyridines as inhibitors of beta-1,6-glucan synthesis. Bioorg. Med. Chem. 2010, 18, 5845-5854.
47. Svidzinski, T.I.E.; Franco, S.L.; Moura, L.M.P.; Oliveira, A.C.P.; Longhini, R. Obtençao de extratos de própolis sobre diferentes condiçoes e avaliaçao de sua atividade antifúngica. Rev. Bras. Farmacogn. 2005, 17, 388-395.
48. Franco, S.L.; Svidzinski, T.I.E.; Ogawa, S.E.N.; Novelo, C.R. Composiçoes Farmacêuticas com Atividade Antifúngica Contendo Extratos de Cymbopogon nardus, Processo de Obtençao dos Extratos de Cymbopogon nardus e seus usos. Braz. Patent number BRPI0702622 (WO2008113146), 25 September 2008.
49. Ferreira, I.C.P.; Estivalet, T.I.E.; Tsuzuki, J.C.; Cortez, D.A.G. Uso do Extrato da Planta Sapindus saponaria e de seus Princípios Ativos Para o Controle e Tratamento de Infecçoes por Fungos. Braz. Patent BRPI0506075, 12 September 2005.
50. Shinobu-Mesquita, C.S.; Bertoni, T.A.; Guilhermetti, E.; Svidzinski, T.I.E.I.E. Antifungal activity of the extract of Curcuma zedoaria (christm.) roscoe, zingiberaceae, against yeasts of the genus Candida isolated from the oral cavity of patients infected with the human immunodeficiency virus. Rev. Bras. Farmacogn. 2011, 21, 128-132.
51. Pessini, G.L.; Holetz, F.B.; Sanches, N.R.; Cortez, D.A.G.; Dias Filho, B.P.; Nakamura, C.V. Avaliaçao da atividade antibacteriana e antifúngica de extratos de plantas utilizados na medicina popular. Rev. Bras. Farmacogn. 2003, 13, 21-24.
52. Tempone, A.G.; Sartorelli, P.; Teixeira, D.; Prado, F.O.; Calixto, I.A.R.L.; Lorenzi, H.; Melhem, M.S.C. Brazilian flora extracts as source of novel antileishmanial and antifungal compounds. Mem. Inst. Oswaldo Cruz 2008, 103, 443-449.
53. Rajeh, M.A.B.; Zuraini, Z.; Sasidharan, S.; Latha, L.Y.; Amutha, S. Assessment of Euphorbia hirta L. leaf, flower, stem and root extracts for their antibacterial and antifungal activity and brine shrimp lethality. Molecules 2010, 15, 6008-6018.
54. Polaquini, S.R.B.; Svidzinski, T.I.E.; Kemmelmeier, C.; Gasparetto, A. Effect of aqueous extract from neem (Azadirachta indica A. Juss) on hydrophobicity, biofilm formation and adhesion in composite resin by Candida albicans. Arch. Oral Biol. 2006, 51, 482-490.
55. Nino, J.; Mosquera, O.M.; Correa, Y.M. Antibacterial and antifungal activities of crude plant extracts from colombian biodiversity. Rev. Biol. Trop. 2012, 60, 1535-1542.
56. Zabka, M.; Pavela, R.; Gabrielova-Slezakova, L. Promising antifungal effect of some euro-asiatic plants against dangerous pathogenic and toxinogenic fungi. J. Sci. Food Agric. 2011, 91, 492-497.
57. Madhumitha, G.; Saral, A.M. Preliminary phytochemical analysis, antibacterial, antifungal and anticandidal activities of successive extracts of Crossandra. infundibuliformis. Asian Pac. J. Trop. Med. 2011, 4, 192-195.
58. Karimi, E.; Jaafar, H.Z.E.; Ahmad, S. Antifungal, anti-inflammatory and cytotoxicity activities of three varieties of Labisia pumila benth: From microwave obtained extracts. BMC Complement. Altern. Med. 2013, 13, 20.
59. Hamza, O.J.M.; van den Bout-Van den Beukel, C.J.P.; Matee, M.I.N.; Moshi, M.J.; Mikx, F.H.M.; Selemani, H.O.; Mbwambo, Z.H.; van der Ven, A.J.A.M.; Verweij, P.E. Antifungal activity of some tanzanian plants used traditionally for the treatment of fungal infections. J. Ethnopharmacol. 2006, 108, 124-132.
60. Phongpaichit, S.; Subhadhirasakul, S.; Wattanapiromsakul, C. Antifungal activities of extracts from thai medicinal plants against opportunistic fungal pathogens associated with aids patients. Mycoses 2005, 48, 333-338.
61. Naghdi, B.H.; Soroushzadeh, A.; Rezazadeh, S.A.; Sharifi, M.; Ghalavand, A.; Rezaei, A. Evaluation of phytochemical and production potential of borage (Borago. officinalis L.) during the growth cycle. J. Med. Plants 2008, 7, 37-43.
62. Binns, S.E.; Arnason, J.T.; Baum, B.R. Phytochemical variation within populations of Echinacea angustifolia (asteraceae). Biochem. Sys. Ecol. 2002, 30, 837-854.
63. Zhao, Y.P.; Li, J.H.; Yang, S.T.; Fan, J.; Fu, C.X. Effects of postharvest processing and geographical source on phytochemical variation of Corydalis rhizoma. Chin. Herbal Med. 2013, 5, 151-157.
64. Silva-Santos, A.; Antunes, A.M.S.; Bizzo, H.R.; d'Avila, L.A. A participaçao da indústria óleo-citrícola na balança comercial brasileira. Rev. Bras. Plant. Med. 2006, 8, 8-13.
65. Craveiro, A.A.; Queiroz, D.C. Óleos essenciais e química fina. Quím. Nova 1993, 16, 224-228.
66. Karlberg, A.T.; Dooms-Goossens, A. Contact allergy to oxidized d-limonene among dermatitis patients. Contact Derm. 1997, 36, 201-206.
67. Siani, A.C.; Sampaio, A.L.F.; Souza, M.C.; Henriques, M.; Ramos, M.F.S. Óleos essenciais: Potencial antiinflamatório. Biotecnol.: Ciênc. Desenvolv. 2000, 16, 38-43.
68. Maruzzella, J.C.; Liguori, L. The in vitro antifungal activity of essential oils. J. Am. Pharm. Assoc. 1958, 47, 250-254.
69. Toama, M.A.; El-Alfy, T.S.; El-Fatatry, H.M. Antimicrobial activity of the volatile oil of Nigella. sativa linneaus seeds. Antimicrob. Agents Chemother. 1974, 6, 225-226.
70. Banerjee, A.; Nigam, S.S. Antifungal activity of the essential oil of Curcuma caesia roxb. Indian J. Med. Res. 1976, 64, 1318-1321.
71. Nenoff, P.; Haustein, U.F.; Brandt, W. Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Skin Pharmacol. 1996, 9, 388-394.
72. Mastura, M.; Azah, M.A.N.; Khozirah, S.; Mawardi, R.; Manaf, A.A. Anticandidal and antidermatophytic activity of Cinnamomum species essential oils. Cytobios 1999, 98, 17-23.
73. Viollon, C.; Chaumont, J.-P. Antifungal properties of essential oils and their main components upon Cryptococcus neoformans. Mycopathologia 1994, 128, 151-153.
74. Corrêa, M.P. Dicionário de Plantas úteis do Brasil e das Exóticas Cultivadas; Ministério da Agricultura, Instituto Brasileiro de Desenvolvimento Florestal: Rio de Janeiro, Brasil, 1984.
75. Cortez, D.A.G.; Cortez, L.E.R., Pessini, G.L.; Doro, D.L.; Nakamura, C.V. Analysis of essential oil of alfavaca Ocimum. gratissimum L. (labiatae). Arq. Ciênc. Saúde UNIPAR 1998, 2, 125-127.
76. De Oliveira Lima, I.; Oliveira, R.D.A.G.; de Oliveira Lima, E.; Farias, N.M.P.; de Souza, E.L. Atividade antifúngica de óleos essenciais sobre espécies de Candida. Rev. Bras. Farmacogn. 2006, 16, 197-201.
77. Ribeiro, D.I.; Alves, M.D.S.; Faria, M.G.I.; Svidzinski, T.I.E.; Nascimento, I.A.; Ferreira, F.B.P.; Ferreira, G.A.; Gazim, Z.C. Determination of antifungal activity of essential oils of Curcuma longa L. (Zingiberaceae) and Achillea. millefolium (Asteraceae) grown in the northwest Paraná. Arq. Ciênc. Saúde UNIPAR 2010, 14, 103-109.
78. Bajpai, V.K.; Yoon, J.I.; Kang, S.C. Antifungal potential of essential oil and various organic extracts of Nandina domestica thunb. against skin infectious fungal pathogens. Appl. Microbiol. Biotechnol. 2009, 83, 1127-1133.
79. Pandey, A.K.; Mishra, A.K.; Mishra, A. Antifungal and antioxidative potential of oil and extracts derived from leaves of indian spice plant Cinnamomum tamala. Cell. Mol. Biol. 2012, 58, 142-147.
80. Carmo, E.S.; Pereira, F.d.O.; Cavalcante, N.M.; Gayoso, C.W.; Lima, E.O. Treatment of pityriasis versicolor with topical application of essential oil of Cymbopogon citratus (DC) stapf-therapeutic pilot study. An. Bras. Dermatol. 2013, 88, 381-385.
81. Bouzabata, A.; Bazzali, O.; Cabral, C.; Gonçalves, M.J.; Teresa Cruz, M.; Bighelli, A.; Cavaleiro, C.; Casanova, J.; Salgueiro, L.; Tomi, F. New compounds, chemical composition, antifungal activity and cytotoxicity of the essential oil from Myrtus nivellei batt. & trab., an endemic species of central sahara. J. Ethnopharmacol. 2013, 149, 613-620.
82. Sookto, T.; Srithavaj, T.; Thaweboon, S.; Thaweboon, B.; Shrestha, B.; Nakazawa, F. In vitro effects of Salvia officinalis L. essential oil on Candida albicans. Asian Pac. J. Trop. Biomed. 2013, 3, 376-380.
83. Souza, E.L.D.; Lima, E.D.O.; Freire, K.R.D.L.; Sousa, C.P.D. Inhibitory action of some essential oils and phytochemicals on the growth of various moulds isolated from foods. Braz. Arch. Biol. Technol. 2005, 48, 245-250.
84. Flach, A.; Gregel, B.; Simionatto, E.; da Silva, U.F.; Zanatta, N.; Morel, A.F.; Linares, C.E.B.; Alves, S.H. Chemical analysis and antifungal activity of the essential oil of Calea. clematidea. Planta Med. 2002, 68, 836-838.
85. Pinto, E.; Salgueiro, L.R.; Cavaleiro, C.; Palmeira, A.; Gonçalves, M.J. In vitro susceptibility of some species of yeasts and filamentous fungi to essential oils of Salvia officinalis. Ind. Crop. Prod. 2007, 26, 135-141.
86. Gazim, Z.C.; Rezende, C.M.; Fraga, S.R.; Svidzinski, T.I.E.; Cortez, D.A.G. Antifungal activity of the essential oil from Calendula officinalis L. (Asteraceae) growing in Brazil. Braz. J. Microbiol. 2008, 39, 61-63.
87. Silva, D.R.; Endo, E.H.; Nakamura, C.V.; Svidzinski, T.I.E.; de Souza, A.; Young, M.C.M.; Ueda-Nakamura, T.; Cortez, D.A.G. Chemical composition and antimicrobial properties of Piper ovatum Vahl. Molecules 2009, 14, 1171-1182.
88. Nakamura, C.V.; de Paulo, L.F.; Young, M.C.M.; Svidzinski, T.I.E.I.E., Chemical composition and antifungal activity of the essential oil from Piper amalago L. Lat. Am. J. Pharm. 2010, 29, 1459-1462.
89. Taweechaisupapong, S.; Singhara, S.; Lertsatitthanakorn, P.; Khunkitti, W. Antimicrobial effects of Boesenbergia. pandurata and Piper sarmentosum leaf extracts on planktonic cells and biofilm of oral pathogens. Pak. J. Pharm. Sci. 2010, 23, 224-231.
90. Silva, F.; Ferreira, S.; Duarte, A.; Mendonça, D.I.; Domingues, F.C. Antifungal activity of Coriandrum sativum essential oil, its mode of action against Candida species and potential synergism with amphotericin B. Phytomedicine 2011, 19, 42-47.
91. Vieira, S.C.H.; Paulo, L.F.D.; Svidzinski, T.I.E.; Dias Filho, B.P.; Nakamura, C.V.; Souza, A.D.; Young, M.C.M.; Cortez, D.A.G. Antifungal activity of Piper diospyrifolium Kunth (Piperaceae) essential oil. Braz. J. Microbiol. 2011, 42, 1001-1006.
92. Saharkhiz, M.J.; Motamedi, M.; Zomorodian, K.; Pakshir, K.; Miri, R.; Hemyari, K. Chemical composition, antifungal and antibiofilm activities of the essential oil of Mentha. piperita L. ISRN Pharm. 2012, 2012, 1-6.
93. Mello, J.C.P.D.; Mentz, L.A.; Petrovick, P.R. Farmacognosia: Da Planta ao Medicamento; Porto Alegre, EFRGS: Porto Alegre, Brazil, 2003.
94. Barchiesi, F.; Silvestri, C.; Arzeni, D.; Ganzetti, G.; Castelletti, S.; Simonetti, O.; Cirioni, O.; Kamysz, W.; Kamysz, E.; Spreghini, E. In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. Med. Mycol. 2008, 47, 321-326.
95. Hammer, K.A.; Carson, C.F.; Riley, T.V. Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans. Med. Mycol. 2000, 38, 354-361.
96. Palmeira-de-Oliveira, A.; Salgueiro, L.; Palmeira-de-Oliveira, R.; Martinez-de-Oliveira, J.; Pina-Vaz, C.; Queiroz, J.A.; Rodrigues, A.G. Anti-candida activity of essential oils. Mini. Rev. Med. Chem. 2009, 9, 1292-1305.
97. Pauli, A. Anticandidal low molecular compounds from higher plants with special reference to compounds from essential oils. Med. Res. Rev. 2006, 26, 223-268.
98. Marcos-Arias, C.; Eraso, E.; Madariaga, L.; Quindós, G. In vitro activities of natural products against oral Candida isolates from denture wearers. BMC Complement. Altern. Med. 2011, 11, 119-126.
99. Machumi, F.; Samoylenko, V.; Yenesew, A.; Derese, S.; Midiwo, J.O.; Wiggers, F.T.; Jacob, M.R.; Tekwani, B.L.; Khan, S.I.; Walker, L.A. Antimicrobial and antiparasitic abietane diterpenoids from the roots of Clerodendrum. eriophyllum. Nat. Prod. Commun. 2010, 5, 853-858.
100. Amber, K.; Aijaz, A.; Immaculata, X.; Luqman, K.A.; Nikhat, M. Anticandidal effect of Ocimum sanctum essential oil and its synergy with fluconazole and ketoconazole. Phytomedicine 2010, 17, 921-925.
101. Burdock, G.A. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem. Toxicol. 1998, 36, 347-363.
102. Bankova, V.S.; de Castro, S.L.; Marcucci, M.C. Propolis: Recent advances in chemistry and plant origin. Apidologie 2000, 31, 3-16.
103. Teixeira, E.W.; Negri, G.; Salatino, A.; Stringheta, P.C. Seasonal variation, chemical composition and antioxidant activity of Brazilian propolis samples. Evid. Based Complement. Alternat. Med. 2010, 7, 307-315.
104. Monzote, L.; Cuesta-Rubio, O.; Campo Fernandez, M.; Márquez Hernandez, I.; Fraga, J.; Pérez, K.; Kerstens, M.; Maes, L.; Cos, P. In vitro antimicrobial assessment of Cuban propolis extracts. Mem. Inst. Oswaldo Cruz 2012, 107, 978-984.
105. Bonvehí, J.S.; Gutiérrez, A.L. The antimicrobial effects of propolis collected in different regions in the Basque country (northern Spain). World J. Microbiol. Biotechnol. 2012, 28, 1351-1358.
106. Kujumgiev, A.; Tsvetkova, I.; Serkedjieva, Y.; Bankova, V.; Christov, R.; Popov, S. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J. Ethnopharmacol. 1999, 64, 235-240.
107. Ota, C.; Unterkircher, C.; Fantinato, V.; Shimizu, M.T. Antifungal activity of propolis on different species of Candida. Mycoses 2001, 44, 375-378.
108. Dalben-Dota, K.F.; Faria, M.G.I.; Bruschi, M.L.; Pelloso, S.M.; Lopes-Consolaro, M.E.; Svidzinski, T.I.E.I.E., Antifungal activity of propolis extract against yeasts isolated from vaginal exudates. J. Altern. Complement. Med. 2010, 16, 285-290.
109. Oliveira, A.C.P.; Shinobu, C.S.; Longhini, R.; Franco, S.L.; Svidzinski, T.I.E.I.E., Antifungal activity of propolis extract against yeasts isolated from onychomycosis lesions. Mem. Inst. Oswaldo Cruz 2006, 101, 493-497.
110. Fernandes, F.F.; Dias, A.L.T.; Ramos, C.L.; Ikegaki, M.; Siqueira, A.M.D.; Franco, M.C. The "in vitro" antifungal activity evaluation of propolis g12 ethanol extract on Cryptococcus neoformans. Rev. Inst. Med. Trop. Sao Paulo 2007, 49, 93-95.
111. Murad, J.M.; Calvi, S.A.; Soares, A.; Bankova, V.; Sforcin, J.M. Effects of propolis from Brazil and Bulgaria on fungicidal activity of macrophages against Paracoccidioides brasiliensis. J. Ethnopharmacol. 2002, 79, 331-334.
112. Avanço, G.B.; Bruschi, M.L. Preparation and characterisation of ethylcellulose microparticles containing propolis. Rev. Ciênc. Farm. Básica Apl. 2009, 29, 129-135.
113. Dota, K.F.D.; Consolaro, M.E.L.; Svidzinski, T.I.E.; Bruschi, M.L. Antifungal activity of Brazilian propolis microparticles against yeasts isolated from vulvovaginal candidiasis. Evid. Based Complement. Alternat. Med. 2011, 2011, 201953.
114. Harris, J.C.; Cottrell, S.; Plummer, S.; Lloyd, D. Antimicrobial properties of Allium sativum (garlic). Appl. Microbiol. Biotechnol. 2001, 57, 282-286.
115. Block, E. The organosulfur chemistry of the genus allium-implications for the organic chemistry of sulfur. Angewandte. Chemie. Angew. Chem. Int. Ed. Engl. 1992, 31, 1135-1178.
116. Yoshida, H.; Iwata, N.; Katsuzaki, H.; Naganawa, R.; Ishikawa, K.; Fukuda, H.; Fujino, T.; Suzuki, A. Antimicrobial activity of a compound isolated from an oil-macerated garlic extract. Biosci. Biotechnol. Biochem. 1998, 62, 1014-1017.
117. Rev, N. Efectos del ajoeno sobre dermatofitos, Candida albicans y Malassezia furfur. Rev. Iberoam. Micol. 1998, 15, 277-281.
118. Ledezma, E.; Apitz-Castro, R. Ajoene the main active compound of garlic (Allium sativum): A new antifungal agent. Rev. Iberoam. Micol. 2006, 23, 75-80.
119. Yoshida, S.; Kasuga, S.; Hayashi, N.; Ushiroguchi, T.; Matsuura, H.; Nakagawa, S. Antifungal activity of ajoene derived from garlic. Appl. Environ. Microbiol. 1987, 53, 615-617.
120. Davis, S.R.; Perrie, R.; Apitz-Castro, R. The in vitro susceptibility of Scedosporium prolificans to ajoene, allitridium and a raw extract of garlic (Allium sativum). J. Antimicrob. Chemother. 2003, 51, 593-597.
121. San-Blas, G.; San-Blas, F.; Gil, F.; Marino, L.; Apitz-Castro, R. Inhibition of growth of the dimorphic fungus Paracoccidioides brasiliensis by ajoene. Antimicrob. Agents Chemother. 1989, 33, 1641-1644.
122. Visbal, G.; San-Blas, G.; Murgich, J.; Franco, H. Paracoccidioides brasiliensis, paracoccidioidomycosis, and antifungal antibiotics. Curr. Drug Targets Infect. Disord. 2005, 5, 211-226.
123. Alastruey-Izquierdo, A.; Cuenca-Estrella, M.; Monzón, A.; Mellado, E.; Rodríguez-Tudela, J.L. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J. Antimicrob. Chemother. 2008, 61, 805-809.
124. Lalitha, P.; Shapiro, B.L.; Srinivasan, M.; Prajna, N.V.; Acharya, N.R.; Fothergill, A.W.; Ruiz, J.; Chidambaram, J.D.; Maxey, K.J.; Hong, K.C. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Arch. Ophthalmol. 2007, 125, 789-793.
125. Lewis, R.E.; Wiederhold, N.P.; Klepser, M.E. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp. Antimicrob. Agents Chemother. 2005, 49, 945-951.
126. San-Blas, G.; Marino, L.; San-Blas, F.; Apitz-Castro, R. Effect of ajoene on dimorphism of Paracoccidioides brasiliensis. Med. Mycol. 1993, 31, 133-141.
127. Maluf, M.L.; Takahachi, G.; Svidzinski, T.I.; Xander, P.; Apitz-Castro, R.; Bersani-Amado, C.A.; Cuman, R.K.N. Antifungal activity of ajoene on experimental murine paracoccidioidomycosis. Rev. Iberoam. Micol. 2008, 25, 163-166.
128. Ledezma, E.; Marcano, K.; Jorquera, A.; de Sousa, L.; Padilla, M.; Pulgar, M.; Apitz-Castro, R. Efficacy of ajoene in the treatment of tinea pedis: A double-blind and comparative study with terbinafine. J. Am. Acad. Dermatol. 2000, 43, 829-832.
129. Ledezma, E.; Sousa, L.D.; Jorquera, A.; Sanchez, J.; Lander, A.; Rodriguez, E.; Jain, M.K.; Apitz-Castro, R. Efficacy of ajoene, an organosulphur derived from garlic, in the short-term therapy of tinea pedis. Mycoses 1996, 39, 393-395.
130. Ledezma, E.; López, J.C.; Marin, P.; Romero, H.; Ferrara, G.; de Sousa, L.; Jorquera, A.; Castro, R.A. Ajoene in the topical short-term treatment of tinea cruris and tinea corporis in humans. Arzneimittelforschung 1999, 49, 544-547.
131. Pérez-Blanco, M.; Hernández Valles, R.; Fernández Zeppenfeldt, G.; Apitz-Castro, R. Ajoene and 5-fluorouracil in the topical treatment of Cladophialophora carrionii chromoblastomycosis in humans: A comparative open study. Med. Mycol. 2003, 41, 517-520.
132. Marston, A.; Hostettmann, K. Review article number 6: Plant molluscicides. Phytochemistry 1985, 24, 639-652.
133. Connolly, J.D.; Hill, R.A. Triterpenoids. Nat. Prod. Rep. 2005, 22, 230-248.
134. Phillips, D.R.; Rasbery, J.M.; Bartel, B.; Matsuda, S. Biosynthetic diversity in plant triterpene cyclization. Curr. Opin. Plant. Biol. 2006, 9, 305-314.
135. Vincken, J.-P.; Heng, L.; de Groot, A.; Gruppen, H. Saponins, classification and occurrence in the plant kingdom. Phytochemistry 2007, 68, 275-297.
136. Yendo, A.C.A.; de Costa, F.; Gosmann, G.; Fett-Neto, A.G. Production of plant bioactive triterpenoid saponins: Elicitation strategies and target genes to improve yields. Mol. Biotechnol. 2010, 46, 94-104.
137. Osbourn, A.E. Saponins in cereals. Phytochemistry 2003, 62, 1-4.
138. Dini, I.; Tenore, G.C.; Schettino, O.; Dini, A. New oleanane saponins in Chenopodium. quinoa. J. Agric. Food Chem. 2001, 49, 3976-3981.
139. Dini, I.; Schettino, O.; Simioli, T.; Dini, A. Studies on the constituents of Chenopodium quinoa seeds: Isolation and characterization of new triterpene saponins. J. Agric. Food Chem. 2001, 49, 741-746.
140. Sparg, S.G.; Light, M.E.; van Staden, J. Biological activities and distribution of plant saponins. J. Ethnopharmacol. 2004, 94, 219-243.
141. Escalante, A.M.; Santecchia, C.B.; López, S.N.; Gattuso, M.A.; Gutiérrez Ravelo, A.; Delle Monache, F.; Gonzalez Sierra, M.; Zacchino, S.A. Isolation of antifungal saponins from Phytolacca tetramera, an Argentinean species in critic risk. J. Ethnopharmacol. 2002, 82, 29-34.
142. Liberto, M.D.; Svetaz, L.; Furlán, R.L.E.; Zacchino, S.A.; Delporte, C.; Novoa, M.A.; Asencio, M.; Cassels, B.K. Antifungal activity of saponin-rich extracts of Phytolacca dioica and of the sapogenins obtained through hydrolysis. Nat. Prod. Commun. 2010, 5, 1013-1018.
143. Houghton, P.; Patel, N.; Jurzysta, M.; Biely, Z.; Cheung, C. Antidermatophyte activity of medicago extracts and contained saponins and their structure-activity relationships. Phytother. Res. 2006, 20, 1061-1066.
144. Zhang, J.D.; Cao, Y.B.; Xu, Z.; Sun, H.H.; An, M.M.; Yan, L.; Chen, H.S.; Gao, P.H.; Wang, Y.; Jia, X.M. In vitro and in vivo antifungal activities of the eight steroid saponins from Tribulus terrestris L. with potent activity against fluconazole-resistant fungal. Biol. Pharm. Bull. 2005, 28, 2211-2215.
145. Zhang, J.D.; Xu, Z.; Cao, Y.B.; Chen, H.S.; Yan, L.; An, M.M.; Gao, P.H.; Wang, Y.; Jia, X.M.; Jiang, Y.Y. Antifungal activities and action mechanisms of compounds from Tribulus terrestris L. J. Ethnopharmacol. 2006, 103, 76-84.
146. Coleman, J.J.; Okoli, I.; Tegos, G.P.; Holson, E.B.; Wagner, F.F.; Hamblin, M.R.; Mylonakis, E. Characterization of plant-derived saponin natural products against Candida albicans. ACS Chem. Biol. 2010, 5, 321-332.
147. Tsuzuki, J.K.; Svidzinski, T.I.E.; Shinobu, C.S.; Silva, L.F.A.; Rodrigues-Filho, E.; Cortez, D.A.G.; Ferreira, I.C.P. Antifungal activity of the extracts and saponins from Sapindus saponaria L. Anais Acad. Bras. Ciênc. 2007, 79, 577-583.
148. Damke, E.; Tsuzuki, J.K.; Cortez, D.A.; Ferreira, I.C.; Bertoni, T.A.; Batista, M.R.; Donati, L.; Svidzinski, T.I.; Consolaro, M.E. In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species. BMC Complement. Altern. Med. 2011, 11, 35.
149. Evans, W.C. Trease and Evans' Pharmacognosy; Elsevier Health Sciences: New York, NY, USA, 2009.
150. Mollataghi, A.; Coudiere, E.; Hadi, A.H.A.; Mukhtar, M.R.; Awang, K.; Litaudon, M.; Ata, A. Anti-acetylcholinesterase, anti-a-glucosidase, anti-leishmanial and anti-fungal activities of chemical constituents of Beilschmiedia species. Fitoterapia 2012, 83, 298-302.
151. Meng, F.; Zuo, G.; Hao, X.; Wang, G.; Xiao, H.; Zhang, J.; Xu, G. Antifungal activity of the benzo[c]phenanthridine alkaloids from Chelidonium. majus Linn against resistant clinical yeast isolates. J. Ethnopharmacol. 2009, 125, 494-496.
152. Rankovic, B.; Rankovic, D.; Maric, D. Antioxidant and antimicrobial activity of some Lichen species. Microbiology 2010, 79, 809-815.
153. Ayala-Zavala, J.F.; Silva-Espinoza, B.A.; Cruz-Valenzuela, M.R.; Villegas-Ochoa, M.A.; Esqueda, M.; González-Aguilar, G.A.; Calderón-López, Y. Antioxidant and antifungal potential of methanol extracts of Phellinus spp. from sonora, mexico. Rev. Iberoam. Micol. 2012, 29, 132-138.
154. Vijayarathna, S.; Zakaria, Z.; Chen, Y.; Latha, L.Y.; Kanwar, J.R.; Sasidharan, S. The antimicrobial efficacy of Elaeis guineensis: Characterization, in vitro and in vivo studies. Molecules 2012, 17, 4860-4877.
155. Kumar, R.S.; Sivakumar, T.; Sunderam, R.S.; Gupta, M.; Mazumdar, U.K.; Gomathi, P.; Rajeshwar, Y.; Saravanan, S.; Kumar, M.S.; Murugesh, K. Antioxidant and antimicrobial activities of Bauhinia racemosa L. Stem bark. Braz. J. Med. Biol. Res. 2005, 38, 1015-1024.
156. Chaieb, K.; Zmantar, T.; Ksouri, R.; Hajlaoui, H.; Mahdouani, K.; Abdelly, C.; Bakhrouf, A. Antioxidant properties of the essential oil of Eugenia caryophyllata and its antifungal activity against a large number of clinical Candida species. Mycoses 2007, 50, 403-406.
157. ElSohly, H.N.; Joshi, A.S.; Nimrod, A.C.; Walker, L.A.; Clark, A.M. Antifungal chalcones from Maclura. tinctoria. Planta Med. 2001, 67, 87-89.
158. Sathiamoorthy, B.; Gupta, P.; Kumar, M.; Chaturvedi, A.K.; Shukla, P.K.;
159. Martins, C.V.B.; da Silva, D.L.; Neres, A.T.M.; Magalhaes, T.F.F.; Watanabe, G.A.; Modolo, L.V.; Sabino, A.A.; de Fátima, A.; de Resende, M.A. Curcumin as a promising antifungal of clinical interest. J. Antimicrob. Chemother. 2009, 63, 337-339.
160. Mbaveng, A.T.; Kuete, V.; Ngameni, B.; Beng, V.P.; Ngadjui, B.T.; Meyer, J.J.M.; Lall, N. Antimicrobial activities of the methanol extract and compounds from the twigs of Dorstenia mannii (Moraceae). BMC Complement. Alter. Med. 2012, 12, 83-88.
161. Sanguinetti, M.; Posteraro, B.; Romano, L.; Battaglia, F.; Lopizzo, T.; de Carolis, E.; Fadda, G. In vitro activity of Citrus bergamia (Bergamot) oil against clinical isolates of dermatophytes. J. Antimicrob. Chemother. 2007, 59, 305-308.
162. Verzera, A.; Trozzi, A.; Gazea, F.; Cicciarello, G.; Cotroneo, A. Effects of rootstock on the composition of bergamot (Citrus bergamia risso et poiteau) essential oil. J. Agric. Food Chem. 2003, 51, 206-210.
163. Romano, L.; Battaglia, F.; Masucci, L.; Sanguinetti, M.; Posteraro, B.; Plotti, G.; Zanetti, S.; Fadda, G. In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates. J. Antimicrob. Chemother. 2005, 55, 110-114.
164. Fotie, J.; Bohle, D.S. Pharmacological and biological activities of xanthones. Antiinfect. Agents Med. Chem. 2006, 5, 15-31.
165. Sousa, M.E.; Pinto, M.M.M. Synthesis of xanthones: An overview. Curr. Med. Chem. 2005, 12, 2447-2479.
166. Na, Y. Recent cancer drug development with xanthone structures. J. Pharm. Pharmacol. 2009, 61, 707-712.
167. Pinto, D.C.G.; Fuzzati, N.; Pazmino, X.C.; Hostettmann, K. Xanthone and antifungal constituents from Monnina obtusifolia. Phytochemistry 1994, 37, 875-878.
168. Pinto, E.; Afonso, C.; Duarte, S.; Vale-Silva, L.; Costa, E.; Sousa, E.; Pinto, M. Antifungal activity of xanthones: Evaluation of their effect on ergosterol biosynthesis by high-performance liquid chromatography. Chem. Biol. Drug Des. 2011, 77, 212-222.
169. Tocci, N.; D'Auria, F.D.; Simonetti, G.; Panella, S.; Palamara, A.T.; Debrassi, A.; Clovis, A.R.; Cechinel Filho, V.; Sciubba, F.; Pasqua, G. Bioassay-guided fractionation of extracts from Hypericum perforatum in vitro roots treated with carboxymethylchitosans and determination of antifungal activity against human fungal pathogens. Plant Physiol. Biochem. 2013, 70, 342-347.
170. Peterson, J.; Dwyer, J.; Adlercreutz, H.; Scalbert, A.; Jacques, P.; McCullough, M.L. Dietary lignans: Physiology and potential for cardiovascular disease risk reduction. Nutr. Rev. 2010, 68, 571-603.
171. Kim, M.-R.; Moon, H.T.; Lee, D.G.; Woo, E.-R. A new lignan glycoside from the stem bark of Styrax japonica s. Et z. Arch. Pharm. Res. 2007, 30, 425-430.
172. Park, C.; Woo, E.-R.; Lee, D.G. Anti-candida property of a lignan glycoside derived from Styrax japonica s. Et z. via membrane-active mechanisms. Mol. Cells 2010, 29, 581-584.
173. Koroishi, A.M.; Foss, S.R.; Cortez, D.A.G.; Ueda-Nakamura, T.; Nakamura, C.V.; Dias Filho, B.P. In vitro antifungal activity of extracts and neolignans from Piper regnellii against dermatophytes. J. Ethnopharmacol. 2008, 117, 270-277.
174. Liu, M.; Katerere, D.R.; Gray, A.I.; Seidel, V. Phytochemical and antifungal studies on Terminalia. mollis and Terminalia brachystemma. Fitoterapia 2009, 80, 369-373.
175. Santos, C.A.D.M.; Torres, K.R.; Leonart, R. Plantas. Medicinais: Herbarium, Flora et Scientia; Medicinal Plants: Herbariun., Flora et Scientia; Scientia et labor: Curitiba, Brazil, 1988.
176. Alzugaray, D.; Alzugaray, C. Plantas Que Curam, 3rd ed.; M.V.P. Publisher: Sao Paulo, Brazil, 1983.
177. Ishida, K.; de Mello, J.C.P.; Cortez, D.A.G.; Dias Filho, B.P.; Ueda-Nakamura, T.; Nakamura, C.V. Influence of tannins from Stryphnodendron adstringens on growth and virulence factors of Candida albicans. J. Antimicrob. Chemother. 2006, 58, 942-949.
178. Ishida, K.; Rozental, S.; de Mello, J.C.P.; Nakamura, C.V. Activity of tannins from Stryphnodendron adstringens on Cryptococcus neoformans: Effects on growth, capsule size and pigmentation. Ann. Clin. Microbiol. Antimicrob. 2009, 8, 29-38.
179. Berdy, J. Bioactive microbial metabolites. J. Antibiot. 2005, 58, 1-26.
180. Demain, A.L.; Sanchez, S. Microbial drug discovery: 80 years of progress. J. Antibiot. 2009, 62, 5-16.
181. Phongpaichit, S.; Rungjindamai, N.; Rukachaisirikul, V.; Sakayaroj, J. Antimicrobial activity in cultures of endophytic fungi isolated from Garcinia species. FEMS Immunol. Med. Microbiol. 2006, 48, 367-372.
182. Gao, X.; Lu, Y.; Xing, Y.; Ma, Y.; Lu, J.; Bao, W.; Wang, Y.; Xi, T. A novel anticancer and antifungus phenazine derivative from a marine actinomycete bm-17. Microbiol. Res. 2012, 167, 616-622.
183. Xu, L.L.; Han, T.; Wu, J.Z.; Zhang, Q.Y.; Zhang, H.; Huang, B.K.; Rahman, K.; Qin, L.P. Comparative research of chemical constituents, antifungal and antitumor properties of ether extracts of Panax ginseng and its endophytic fungus. Phytomedicine 2009, 16, 609-616.
184. Hertzberg, R.P.; Pope, A.J. High-throughput screening: New technology for the 21st century. Curr. Opin. Chem. Boil. 2000, 4, 445-451.
185. Congreve, M.; Murray, C.W.; Blundell, T.L. Keynote review: Structural biology and drug discovery. Drug Discov. Today 2005, 10, 895-907.
186. Kitamura, A.; Someya, K.; Hata, M.; Nakajima, R.; Takemura, M. Discovery of a smallmolecule inhibitor of β-1,6-glucan synthesis. Antimicrob. Agents Chemother. 2009, 53, 670-677.
187. Kitamura, A.; Someya, K.; Okumura, R.; Hata, M.; Takeshita, H.; Nakajima, R. In vitro antifungal activities of D11-2040, a beta-1,6-glucan inhibitor, with or without currently available antifungal drugs. Biol. Pharm. Bull. 2010, 33, 192-197.
188. Bauer, J.R.; Kinast, S.; Burger-Kentischer, A.; Finkelmeier, D.; Kleymann, G.; Rayyan, W.A.; Schröppel, K.; Singh, A.; Jung, G.N.; Wiesmüller, K.H. High-throughput-screening-based identification and structure-activity relationship characterization defined (S)-2-(1-aminoisobutyl) -1- (3-chlorobenzyl) benzimidazole as a highly antimycotic agent nontoxic to cell lines. J. Med. Chem. 2011, 54, 6993-6997.
189. Burger-Kentischer, A.; Finkelmeier, D.; Keller, P.; Bauer, J.; Eickhoff, H.; Kleymann, G.; Rayyan, W.A.; Singh, A.; Schröppel, K.; Lemuth, K. A screening assay based on host-pathogen interaction models identifies a set of novel antifungal benzimidazole derivatives. Antimicrob. Agents Chemother. 2011, 55, 4789-4801.
190. Chaturvedi, S.; Rajkumar, S.S.; Li, X.; Hurteau, G.J.; Shtutman, M.; Chaturvedi, V. Antifungal testing and high-throughput screening of compound library against Geomyces destructans, the etiologic agent of geomycosis (wns) in bats. PLoS One 2011, 6, e17032.
191. Sun, W.; Park, Y.D.; Sugui, J.A.; Fothergill, A.; Southall, N.; Shinn, P.; McKew, J.C.; Kwon-Chung, K.J.; Zheng, W.; Williamson, P.R. Rapid identification of antifungal compounds against exserohilum rostratum using high throughput drug repurposing screens. PloS One 2013, 8, e70506.
192. Macarron, R.; Banks, M.N.; Bojanic, D.; Burns, D.J.; Cirovic, D.A.; Garyantes, T.; Green, D.V.S.; Hertzberg, R.P.; Janzen, W.P.; Paslay, J.W. Impact of high-throughput screening in biomedical research. Nat. Rev. Drug Discov. 2011, 10, 188-195.
193. Sukumar, N.; Krein, M.P.; Embrechts, M.J. Predictive cheminformatics in drug discovery: Statistical modeling for analysis of micro-array and gene expression data. In Bioinformatics and Drug Discovery; Larson, R.S., Ed.; Springer: New York, NY, USA, 2012; Volume 910, pp. 165-194.
194. Bredel, M.; Jacoby, E. Chemogenomics: An emerging strategy for rapid target and drug discovery. Nat. Rev. Genet. 2004, 5, 262-275.
195. Bleicher, K.H.; Böhm, H.J.; Müller, K.; Alanine, A.I. Hit and lead generation: Beyond high-throughput screening. Nat. Rev. Drug Discov. 2003, 2, 369-378.
196. Stumpfe, D.; Ripphausen, P.; Bajorath, J. Virtual compound screening in drug discovery. Future Med. Chem. 2012, 4, 593-602.
197. Basak, S.C. Chemobioinformatics: The advancing frontier of computer-aided drug design in the post-genomic era. Curr. Comput. Aided. Drug Des. 2012, 8, 1-2.
198. Abadio, A.K.R.; Kioshima, E.S.; Teixeira, M.M.; Martins, N.F.; Maigret, B.; Felipe, M.S.S. Comparative genomics allowed the identification of drug targets against human fungal pathogens. BMC Genomics 2011, 12, doi:10.1186/1471-2164-12-75.
199. Pierce, C.G.; Lopez-Ribot, J.L. Candidiasis drug discovery and development: New approaches targeting virulence for discovering and identifying new drugs. Expert Opin. Drug Discov. 2013, 8, 1-10.
200. Pierri, C.L.; Parisi, G.; Porcelli, V. Computational approaches for protein function prediction: A combined strategy from multiple sequence alignment to molecular docking-based virtual screening. Biochim. Biophys. Acta 2010, 1804, 1695-1712.
201. Cavasotto, C.N.; Phatak, S.S. Homology modeling in drug discovery: Current trends and applications. Drug Discov. Today 2009, 14, 676-683.
202. Swinney, D.C.; Anthony, J. How were new medicines discovered? Nat. Rev. Drug Discov. 2011, 10, 507-519.
203. Berne, S.; Podobnik, B.; Zupanec, N.; Novak, M.; Kraševec, N.; Turk, S.; Korošec, B.; Lah, L.; Šuligoj, E.; Stojan, J. Virtual screening yields inhibitors of novel antifungal drug target, benzoate 4-monooxygenase. J. Chem. Inf. Model. 2012, 52, 3053-3063.
204. Morya, V.K.; Kumari, S.; Kim, E.K. Virtual screening and evaluation of ketol-acid reducto-isomerase (kari) as a putative drug target for aspergillosis. Clin. Proteomics 2012, 9, 1-12.
205. Sheng, C.; Wang, W.; Che, X.; Dong, G.; Wang, S.; Ji, H.; Miao, Z.; Yao, J.; Zhang, W. Improved model of lanosterol 14alpha-demethylase by ligand-supported homology modeling: Validation by virtual screening and azole optimization. Chem. Med. Chem. 2010, 5, 390-397.
206. Sheng, C.; Che, X.; Wang, W.; Wang, S.; Cao, Y.; Miao, Z.; Yao, J.; Zhang, W. Design and synthesis of novel triazole antifungal derivatives by structure-based bioisosterism. Eur. J. Med. Chem. 2011, 46, 5276-5282.
207. Zou, Y.; Zhao, Q.; Liao, J.; Hu, H.; Yu, S.; Chai, X.; Xu, M.; Wu, Q. New triazole derivatives as antifungal agents: Synthesis via click reaction, in vitro evaluation and molecular docking studies. Bioorg. Med. Chem. Lett. 2012, 22, 2959-2962.
208. Xu, J.; Cao, Y.; Zhang, J.; Yu, S.; Zou, Y.; Chai, X.; Wu, Q.; Zhang, D.; Jiang, Y.; Sun, Q. Design, synthesis and antifungal activities of novel 1, 2, 4-triazole derivatives. Eur. J. Med. Chem. 2011, 46, 3142-3148.
209. Chai, X.; Yang, G.; Zhang, J.; Yu, S.; Zou, Y.; Wu, Q.; Zhang, D.; Jiang, Y.; Cao, Y.; Sun, Q. Synthesis and biological evaluation of triazole derivatives as potential antifungal agent. Chem. Biol. Drug. Des. 2012, 80, 382-387.
210. Hata, M.; Ishii, Y.; Watanabe, E.; Uoto, K.; Kobayashi, S.; Yoshida, K.-I.; Otani, T.; Ando, A. Inhibition of ergosterol synthesis by novel antifungal compounds targeting c-14 reductase. Med. Mycol. 2010, 48, 613-621.
211. Cadicamo, C.D.; Mortier, M.J.; Wolber, G.; Hell, M.; Heinrich, I.E.; Michel, D.; Semlin, L.; Berger, U.; Korting, H.C.; Höltje, H.; et al. Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans. Biochem. Pharmacol. 2013, 85, 881-887.
212. Amaral, A.C.; Felipe, M.S.S. Nanobiotechnology: An efficient approach to drug delivery of unstable biomolecules. Curr. Protein Pept. Sci. 2013, 14, 588-594.
213. Van de Ven, H.; Paulussen, C.; Feijens, P.B.; Matheeussen, A.; Rombaut, P.; Kayaert, P.; van den Mooter, G.; Weyenberg, W.; Cos, P.; Maes, L. Plga nanoparticles and nanosuspensions with amphotericin B: Potent in vitro and in vivo alternatives to fungizone and ambisome. J. Controlled Release 2012, 161, 795-803.
214. Amaral, A.C.; Bocca, A.L.; Ribeiro, A.M.; Nunes, J.; Peixoto, D.L.G.; Simioni, A.R.; Primo, F.L.; Lacava, Z.G.M.; Bentes, R.; Titze-de-Almeida, R. Amphotericin B in poly (lactic-co-glycolic acid) (plga) and dimercaptosuccinic acid (dmsa) nanoparticles against paracoccidioidomycosis. J. Antimicrob. Chemother. 2009, 63, 526-533.